Maze Therapeutics Inc.

MAZE | NASDAQ

Price Alert Chart Builder DCF Calculator

$27.16

+$4.77 (+21.30%)

Sep 22, 2026, 12:13 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ARDX Ardelyx	N/A
BCRX BioCryst Pharmaceuticals	N/A
IMNM Immunome	N/A
NTLA Intellia Therapeutics	N/A
PHVS Pharvaris	N/A
SION Sionna Therapeutics	N/A
SYRE Spyre Therapeutics	N/A
TRVI Trevi Therapeutics	N/A
WVE Wave Life Sciences	N/A
ZYME Zymeworks	N/A

Dividend Rankings ➞

Recent News

11 days ago / fool.com
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
20 days ago / globenewswire.com
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
27 days ago / seekingalpha.com
Maze Therapeutics: Intriguing Kidney Disease Assets Put This On The Watchlist
1 month ago / globenewswire.com
Maze Therapeutics Announces Appointments to Its Board of Directors
1 month ago / globenewswire.com
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
2 months ago / zacks.com
Can Maze Therapeutics, Inc. (MAZE) Climb 120.48% to Reach the Level Wall Street Analysts Expect?
4 months ago / globenewswire.com
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
4 months ago / fool.com
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
4 months ago / zacks.com
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates
4 months ago / globenewswire.com
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights